XML 21 R13.htm IDEA: XBRL DOCUMENT v3.23.2
NOTE 7 – WARRANTS
3 Months Ended
Jun. 30, 2023
Note 7 Warrants  
NOTE 7 – WARRANTS

NOTE 7 – WARRANTS

 

On October 15, 2020, the Company entered into a service agreement with a third party for a term of six months. Per the terms of the agreement the party was granted 40,000 warrants to purchase shares of common stock. The warrant vested on April 15, 2021. The warrants have an exercise price $0.25 and expire in three years. The aggregate fair value of the warrants totaled $180,000 based on the Black Scholes Merton pricing model using the following estimates: stock price of $4.50, exercise price of $0.25, 1.57% risk free rate, 735.46% volatility and expected life of the warrants of 3 years.

 

A summary of the status of the Company’s outstanding stock warrants and changes during the year is presented below:

 

   Number of Warrants  Weighted
Average
Price
  Weighted
Average
Fair Value
  Aggregate Intrinsic Value
 Outstanding, March 31, 2023    40,000   $0.25   $0.18   $   
 Issued         $     $      —   
 Exercised         $     $      —   
 Expired         $     $      —   
 Exercisable, June 30, 2023    40,000    $0.25   $0.18   $   

   

 

Range of Exercise Prices  Number Outstanding 6/30/2023  Weighted Average Remaining Contractual Life  Weighted Average Exercise Price
$0.25    40,000    .29 years    $0.25 

 

The aggregate intrinsic value represents the total pretax intrinsic value, based on warrants with an exercise price less than the Company’s stock price as of June 30, 2023, which would have been received by the warrant holder had the warrant holder exercised their warrants as of that date.